UPDATE: Baxter (BAX) Sues Becton Dickinson (BDX) Over Alleged Patent Infringement
Get Alerts BAX Hot Sheet
Join SI Premium – FREE
(Updated - November 5, 2015 3:00 PM EST)
Baxter (NYSE: BAX) said to sue Becton Dickinson (NYSE: BDX) over infusion pump patent infringement, according to Bloomberg.
UPDATE - According to the report, the complaint was filed in federal court in Chicago.
The patents in question cover battery gauge, medical infusion pump, and method for automatically controlling the level of medicine.
In the suit, Baxter is seeking cash compensation and an order blocking further use of its inventions.
Shares of BDX are up 0.4 percent Thursday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baxter raises tender offer cap to $600M for senior notes
- Quantum Cyber rejects short-seller's offer to halt reports if lawsuit dropped
- Baxter names John Rogers as CFO, effective October 2026
Create E-mail Alert Related Categories
Insiders' Blog, LitigationSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share